Page results
-
Sustainability in healthcare was top of the agenda on Tuesday when the Department of Health and Social Care selected UCLH as the site to launch a new programme to reduce the reliance on single-use items in the UK health system.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.
-
UCLH Director of Research Professor Bryan Williams and Consultant Neuropsychologist at UCLH Professor Lisa Cipolotti have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science.
-
UCL and UCLH researchers have developed an artificial intelligence-based tool that can assess a patient’s brain tumour scan and provide greater patient-personalised detail to aid their treatment.
-
People infected with coronavirus have a distinct odour that can be detected by trained dogs with a high degree of accuracy, according to new research involving UCLH.
-
Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
File results
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0469 - Total number of referrals to the Nursing and Midwifery Council 2019-2023
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust
-
FOI/2024/0352 - Bed occupancy all sites November 2023 to March 2024
-
FOI/2024/0481 - Holter monitor services
-
FOI/2024/0486 - Diagnostic tests for both point of care testing and laboratory
-
FOI/2024/0493 - Registered Allied Health Professionals (AHP) working in Trust - 2018 to 2024
-
FOI/2024/0495 - Voice, data and network - LAN, WLAN, data centre, WAN/ internet connectivity, SIP, telephony, teams phone system, contact centre
-
FOI/2024/0498 - Requests for BSL/SSE to English interpreters/ deaf blind interpreters